Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05588362
Other study ID # IRB-P00040587
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 1, 2023
Est. completion date December 30, 2023

Study information

Verified date January 2023
Source Boston Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Uncorrected refractive error is a leading cause of visual impairment in children and can impact vision, quality of life, and academic performance. Despite Boston Children's Hospital serving patients from a wide range of socioeconomic backgrounds, there are health disparities in access to eyeglasses as a consequence of patients' health insurance. The investigators will examine whether the use of an in-clinic app for 3-D printed glasses reduces disparities in access to eyeglasses for our patients on Medicaid. The intervention will address social determinants of health and improve pediatric health outcomes namely, how and when children having publicly funded health insurance receive eyeglasses. The short-term objectives are (1) to compare the time to receive glasses between publicly funded MassHealth eyeglasses and an in-clinic order of 3D printed glasses (2) to evaluate compliance with glasses wear in these two groups, and (3) to evaluate visual function and quality-of-life outcomes in these two groups. This prospective randomized control study will evaluate barriers to accessing eyeglasses in school-aged children. The investigators will recruit children enrolled in MassHealth and randomize them into two cohorts: (1) the control group will receive MassHealth glasses as per standard of care, through an optical shop of their choosing, or (2) the intervention group will use an app for immediately ordering glasses (paid for by the study) in clinic following their appointment. The investigators will evaluate the time needed to receive eyeglasses, compliance with glasses wear, quality of life, and visual outcomes between the cohorts at one-, three-, and six-month intervals. Through this project, the investigators will not only evaluate, quantify, and bring awareness to disparities in our patient population, but will also look toward finding a solution through the use of a novel application that addresses many of the barriers faced by patients insured through Medicaid.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 72
Est. completion date December 30, 2023
Est. primary completion date November 30, 2023
Accepts healthy volunteers No
Gender All
Age group 5 Years to 17 Years
Eligibility Inclusion Criteria: - Masshealth insurance - first-time glasses wearers - receive a diagnosis of refractive amblyopia, myopia, hyperopia and/or astigmatism requiring spectacle correction for optimal vision at distance and near. - Glasses must be recommended for full time wear by the attending optometrist or ophthalmologist Exclusion Criteria: - strabismus - developmental or learning delay - other ocular pathology

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Fitz Frames 3-D Printed Glasses
The intervention group will order glasses directly in the office following their exam and consent using an iPad with the help of the research assistant. The iPad will be e-connected to a 3D printed glasses manufacturer (Fitz Frames) through their application, allowing the child (with assistance from the doctor or research assistant) to take various measurements in real time. Sixteen different measurements will be taken including interpupillary distance, face length, face width, and temple measures. The child will be able to choose frame style and order it directly from the manufacturer immediately following the exam. Glasses will be shipped directly to the patient's home (shipping address will be input to the app by the family).

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Boston Children's Hospital Fitz Frames, Inc.

Outcome

Type Measure Description Time frame Safety issue
Primary Compliance Glasses compliance will be assessed with self-reported calendar Six months
Primary Quality of Life Questionnaire Quality of life measures using the PedEyeQ Baseline, will be collected at enrollment visit
Primary Distance visual acuity Linear Snellen optotypes (age >6) or HOTV matching with crowding bars (age <6) Baseline, will be collected at enrollment visit
Primary Distance visual acuity Linear Snellen optotypes (age >6) or HOTV matching with crowding bars (age <6) 0-3 Months, will be collected at 3 month visit
Primary Distance visual acuity Linear Snellen optotypes (age >6) or HOTV matching with crowding bars (age <6) 3-6 Months, will be collected at 6 month visit
Primary Stereoacuity Stereo Fly test Baseline, will be collected at enrollment visit
Primary Stereoacuity Stereo Fly test 0-3 Months, will be collected at 3 month visit
Primary Stereoacuity Stereo Fly test 3-6 Months, will be collected at 6 month visit
Primary Ocular alignment Alternative prism cover test at distance and at near Baseline, will be collected at enrollment visit
Primary Ocular alignment Alternative prism cover test at distance and at near 0-3 Months, will be collected at 3 month visit
Primary Ocular alignment Alternative prism cover test at distance and at near 3-6 Months, will be collected at 6 month visit
Primary Near point of convergence Near point of convergence (break point and recovery) will be measured using an accommodative target Baseline, will be collected at enrollment visit
Primary Near point of convergence Near point of convergence (break point and recovery) will be measured using an accommodative target 0-3 Months, will be collected at 3 month visit
Primary Near point of convergence Near point of convergence (break point and recovery) will be measured using an accommodative target 3-6 Months, will be collected at 6 month visit
Primary Near visual acuity Near visual acuity will be measured at 40 cm using the Rosenbaum card Baseline, will be collected at enrollment visit
Primary Near visual acuity Near visual acuity will be measured at 40 cm using the Rosenbaum card 0-3 Months, will be collected at 3 month visit
Primary Near visual acuity Near visual acuity will be measured at 40 cm using the Rosenbaum card 3-6 Months, will be collected at 6 month visit
Primary Quality of Life Questionnaire- PedEyeQ Quality of life measures using the PedEyeQ 0-3 Months, will be collected at 3 month visit
Primary Quality of Life Questionnaire- PedEyeQ Quality of life measures using the PedEyeQ 3-6 Months, will be collected at 6 month visit
See also
  Status Clinical Trial Phase
Recruiting NCT04923841 - Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine N/A
Active, not recruiting NCT04080128 - Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control N/A
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Completed NCT04604405 - Effects of 650nm Low Energy Light on Human Retina and Choroid Microcirculation N/A
Recruiting NCT05594719 - The Effect of Sun-like Spectrum With Different Spectrum Composition on Retinal Blood Flow N/A
Completed NCT05594732 - The Effects of Different Outdoor Light Exposure Modes on Retinal Blood Flow N/A
Completed NCT04492397 - Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI) N/A
Completed NCT04536571 - Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses N/A
Completed NCT06046209 - Comparing a Monthly Replacement Lens Versus a Daily Disposable Lens N/A
Recruiting NCT06344572 - Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia Phase 3
Recruiting NCT05611294 - Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction N/A
Completed NCT05656885 - Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses N/A
Active, not recruiting NCT05534022 - Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression. N/A
Completed NCT03934788 - the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT03701516 - Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2 N/A
Completed NCT05538754 - Post-Market Evaluation of the EVO ICL N/A
Completed NCT03139201 - Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT02555722 - Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear N/A
Not yet recruiting NCT06009458 - Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear N/A
Recruiting NCT05548478 - Corneal Endothelial Cell Injury Induced by Mitomycin-C N/A